{
    "title": "BRIEF-Novartis CEO Says Still Need Proper Blinded Studies To Determine Which Drugs Have Benefit for COVID-19",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8263957/BRIEF-Novartis-CEO-Says-Still-Need-Proper-Blinded-Studies-To-Determine-Which-Drugs-Have-Benefit-COVID-19.html",
    "date": "2020-04-28",
    "keywords": [
        "ceo",
        "novartis",
        "coronavirus",
        "safety",
        "signal",
        "guidance",
        "study",
        "managing",
        "situation",
        "technology",
        "monitoring",
        "beovu",
        "launch",
        "vasculitis",
        "reason",
        "medicine",
        "health",
        "care",
        "q2",
        "enrollment",
        "trial",
        "hopeful",
        "slowdown",
        "lutathera",
        "kymriah",
        "zolgensma",
        "gene",
        "therapy",
        "year",
        "standard",
        "company",
        "coverage",
        "reporting",
        "john",
        "miller"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}